A series of patients with minimal change nephropathy treated with rituximab during adolescence and adulthood

BACKGROUND: The treatment of immune suppression dependent minimal change nephropathy (MCN) can be challenging and frequently leads to serious complications. In paediatric patients, successful treatment with rituximab is described in steroid-dependent MCN. There is limited information about the poten...

Descripción completa

Detalles Bibliográficos
Autores principales: Dekkers, Marinus J, Groothoff, Jaap W, Zietse, Robert, Betjes, Michiel G H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482035/
https://www.ncbi.nlm.nih.gov/pubmed/26112053
http://dx.doi.org/10.1186/s13104-015-1255-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482035/
https://www.ncbi.nlm.nih.gov/pubmed/26112053
http://dx.doi.org/10.1186/s13104-015-1255-0

Ejemplares similares